Login / Signup

Pediatric subset of primary immunodeficiency patients treated with SCIG: post hoc analysis of SHIFT and IBIS pooled data.

Viviana MoscheseClementina CanessaAntonino TrizzinoBaldassarre MartireGiorgio Maria BoggiaSimona Grazianinull null
Published in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology (2020)
In pediatric PID patients, weekly and biweekly Hizentra® administrations appeared equally effective treatment options.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis
  • randomized controlled trial
  • electronic health record
  • big data
  • clinical trial
  • data analysis